Glenmark Life Sciences Limited
Glenmark Life Sciences Limited is a mainboard IPO raising ₹1,513 Cr at ₹695 – ₹720 a share. It listed on 6 Aug 2021 and trades at ₹1,107 today, +53.7% against its issue price of ₹720. It was subscribed 44× in total.
44.2 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Source documents
What the issuer and the exchanges published. Everything else on this tab is read out of these.
Which institutions were allotted shares before bidding opened, and how many.
Where physical applications could be submitted.
The issuer's own "basis of issue price": the earnings multiples it is asking for, and the peer companies it chose to compare itself against.
The full prospectus — business, financials, risk factors and litigation.
Read-out of the prospectus
A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.